HALEOS LABS Share Price Target 2026 Analyst Forecast Bull and Bear Case
- June 16, 2026
- Posted by: Kunal Singla
- Category: News
The HALEOS LABS share price target 2026 is Rs 1,700, implying approximately 20 percent upside from the current market price of Rs 1,423 (NSE: HALEOSLABS). With Q4 FY26 results released in 2026 and Specialty Chemicals and Research tailwinds in focus, the Rs 1,700 price objective is supported by the FY27 earnings recovery thesis.
HALEOS LABS (NSE: HALEOSLABS) is a Specialty Chemicals and Research company trading at Rs 1,423 with a market capitalisation of Rs 1,423 crore. Analysts have set the HALEOS LABS share price target at Rs 1,700 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for HALEOS LABS including sector tailwinds, key risks, and the bull and bear scenarios.
Click Here – Get Free Investment Predictions
HALEOS LABS Share Price Target 2026: Key Takeaways
- HALEOS LABS share price target 2026: Rs 1,700 (20% upside from CMP Rs 1,423)
- Bull case: Rs 2,050 | Bear case: Rs 1,150
- Ticker: HALEOSLABS | Sector: Specialty Chemicals and Research | MCap: Rs 1,423 crore
- 52W range: Rs 986 to Rs 2,334 | PE: 30x
- Key catalyst: Q4 FY26 results and FY27 earnings recovery confirmation in 2026
- Key risk: FY27 earnings miss or sustained FII outflows from Indian equities
HALEOS LABS Company Overview
HALEOS LABS (NSE: HALEOSLABS) is a specialty chemicals research and manufacturing company focused on developing and producing advanced specialty chemical intermediates and compounds for pharmaceutical and industrial applications. At CMP Rs 1,423 against a 52 week range of Rs 986 to Rs 2,334, the stock is trading at a meaningful discount to its 52 week high. The trailing PE is 30x and the Rs 1,700 analyst target implies approximately 20 percent upside from current levels. Compared to peers in specialty chemicals like Aarti Industries and Fine Organics, HALEOS LABS is positioned as a potential re-rating candidate on FY27 earnings delivery.
| Parameter | Value |
|---|---|
| NSE Ticker | HALEOSLABS |
| Sector | Specialty Chemicals and Research |
| CMP (2026) | Rs 1,423 |
| 52 Week High | Rs 2,334 |
| 52 Week Low | Rs 986 |
| Market Cap | Rs 1,423 crore |
| Trailing PE | 30x |
| 12-Month Analyst Target | Rs 1,700 |
| Bull Case Target | Rs 2,050 |
| Bear Case Target | Rs 1,150 |
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Why Is the HALEOS LABS Share Price Target Set at Rs 1,700 for 2026
FY27 Earnings Recovery and Revenue Acceleration
The HALEOS LABS share price target of Rs 1,700 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating. Until FY27 PAT delivery is confirmed, the Rs 1,700 price objective represents a base case with execution risk attached.
Structural Sector Tailwinds in Specialty Chemicals and Research
The Specialty Chemicals and Research sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. HALEOS LABS’s position among peers in specialty chemicals like Aarti Industries and Fine Organics creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 2,050 bull case to materialise, making sector monitoring essential for investors tracking this stock.
RBI Rate Cut Cycle and Lower Cost of Capital
India’s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For HALEOS LABS, lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 1,700 analyst consensus. This rate environment is a tailwind across the Specialty Chemicals and Research space.
Union Budget 2026-27 Capex Push and Policy Support
Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for HALEOS LABS’s Specialty Chemicals and Research operations. Policy support increases the probability of HALEOS LABS achieving its FY27 earnings targets, which in turn supports the Rs 1,700 price objective set by analysts for 2026.
FII Flow Normalisation After the 2026 Tariff Shock
As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 30x PE, HALEOS LABS is positioned as a beneficiary of institutional reallocation into mid-cap and small-cap Indian stocks. Sustained FII inflow is a necessary condition for re-rating the stock toward the Rs 2,050 bull case scenario.
HALEOS LABS Share Price Targets: Short Term, 12 Month, and Long Term
Short Term HALEOS LABS Share Price Target
Near-term support for HALEOS LABS is anchored near the 52 week low of Rs 986. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a key reference while awaiting the FY27 earnings confirmation that would strengthen the case for the full price objective of Rs 1,700.
12-Month HALEOS LABS Share Price Target 2026
The 12-month HALEOS LABS share price target 2026 is Rs 1,700, implying approximately 20 percent upside from CMP Rs 1,423. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Investors can track live price movement on NSE under the ticker HALEOSLABS to assess progress toward this target.
Long Term HALEOS LABS Share Price Target: FY27 to FY28
The long term HALEOS LABS share price target for the FY27 to FY28 period is Rs 2,050 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in specialty chemicals like Aarti Industries and Fine Organics, and sustained institutional buying are the three conditions that need to align for the stock to reach the Rs 2,050 level over a 2 to 3 year horizon.
Bull Case and Bear Case Scenarios for HALEOS LABS in 2026
Bull Case HALEOS LABS Share Price Target: Rs 2,050
The bull case HALEOS LABS share price target of Rs 2,050 materialises when FY27 earnings beat analyst estimates, Specialty Chemicals and Research tailwinds accelerate beyond consensus, and FII flows return strongly to Indian equities. Under this scenario, HALEOS LABS re-rates toward higher peer multiples, making Rs 2,050 achievable within FY28. The current gap between CMP Rs 1,423 and Rs 2,050 represents approximately 45 percent potential upside.
Bear Case HALEOS LABS Share Price Target: Rs 1,150
The bear case HALEOS LABS share price target of Rs 1,150 materialises if FY27 earnings disappoint, management guides below expectations, or sustained FII outflows depress the broader mid-cap market. Under this scenario, the stock risks testing the 52 week low support near Rs 986, and investors should reassess the investment thesis before adding more capital.
| Scenario | Target | Key Conditions |
|---|---|---|
| Bull Case | Rs 2,050 | FY27 earnings beat, sector re-rating, FII inflows |
| Base Case (Analyst Target) | Rs 1,700 | In-line FY27 delivery, partial FII recovery |
| Bear Case | Rs 1,150 | FY27 miss, guidance cut, FII outflows persist |
Key Risks That Could Derail the HALEOS LABS 2026 Price Objective
Global Macro and US Tariff Headwinds
The prolonged tariff tension triggered by the US reciprocal tariff announcement in 2026 has reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains the most prominent macro risk to the HALEOS LABS share price target of Rs 1,700 and could push the stock toward the bear case of Rs 1,150.
FY27 Earnings Miss and Guidance Risk
Any FY27 earnings miss or downward guidance revision by HALEOS LABS’s management would compress valuation multiples. This is the most direct company-specific risk to the Rs 1,700 analyst price objective. Investors should monitor quarterly results and management commentary closely, especially any signals about demand environment, pricing power, or margin compression in the Specialty Chemicals and Research segment.
Competitive Intensity Among Specialty Chemicals and Research Peers
Intensifying competition from peers in specialty chemicals like Aarti Industries and Fine Organics could compress HALEOS LABS’s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory that underpins the Rs 1,700 analyst target truly is, particularly as new entrants and imports from China disrupt established market structures.
Liquidity Risk and FII Selling Pressure
Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level operational improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns significantly. Investors should size positions carefully and maintain stop losses to protect capital if the broader market de-rating continues through FY27.
How to Invest in HALEOS LABS: A Step-by-Step Approach
Check the Univest Screener for live data
Before considering any investment based on the HALEOS LABS share price target of Rs 1,700, review the company’s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Specialty Chemicals and Research sector demand and competition.
Open a Demat and trading account with a SEBI registered stockbroker to trade HALEOS LABS (NSE: HALEOSLABS) with regulatory protection. Complete KYC, and before executing any order, study the competitive landscape among peers in specialty chemicals like Aarti Industries and Fine Organics to assess whether HALEOS LABS’s competitive position justifies the Rs 1,700 valuation.
Plan your entry using technical and fundamental triggers. The 52 week low of Rs 986 acts as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.
Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio. This is especially important in the Specialty Chemicals and Research space where sectoral cycles, regulatory changes, and commodity price swings can amplify volatility beyond initial expectations.
Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.
Download the Univest iOS App or the Univest Android App to track HALEOS LABS’s live share price and receive daily stock recommendations from SEBI registered analysts.
Disclaimer Note: The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.
FAQs on HALEOS LABS Share Price Target 2026
What is the HALEOS LABS share price target for 2026?
Ans. The HALEOS LABS share price target 2026 is Rs 1,700, implying approximately 20 percent upside from CMP Rs 1,423. The bull case estimate is Rs 2,050 and the bear case is Rs 1,150.
What was the HALEOS LABS share price target for 2025?
Ans. The 2025 price target for HALEOS LABS was based on FY26 earnings projections. The current 2026 analyst consensus stands at Rs 1,700, reflecting FY27 growth potential from CMP Rs 1,423.
Is HALEOS LABS a good investment at Rs 1,423?
Ans. At Rs 1,423, HALEOS LABS offers potential upside toward Rs 1,700 if FY27 earnings recover as projected. Whether the stock is a good buy depends on individual risk appetite, investment horizon, and portfolio goals. Consult a SEBI registered financial advisor before investing.
What are the key risks to the HALEOS LABS share price target 2026?
Ans. Key risks to the HALEOS LABS share price target of Rs 1,700 include FY27 earnings miss, global tariff headwinds, sustained FII outflows, and competitive pressure in the Specialty Chemicals and Research sector. Monitoring quarterly results closely is essential.
What is the 52 week high and low of HALEOS LABS?
Ans. The 52 week high of HALEOS LABS is Rs 2,334 and the 52 week low is Rs 986. At CMP Rs 1,423, the stock is trading below its 52 week high and offers upside potential toward the Rs 1,700 analyst price objective.
What are the main growth catalysts for HALEOS LABS in 2026?
Ans. Primary growth catalysts for HALEOS LABS in 2026 include FY27 PAT recovery, Specialty Chemicals and Research sector tailwinds, RBI rate cuts reducing cost of capital, Union Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.
How does HALEOS LABS compare to its peers?
Ans. HALEOS LABS operates in Specialty Chemicals and Research alongside peers in specialty chemicals like Aarti Industries and Fine Organics. At CMP Rs 1,423 with MCap Rs 1,423 crore, the company is positioned as a potential re-rating candidate toward the HALEOS LABS share price target of Rs 1,700 on FY27 earnings delivery.
What is the HALEOS LABS share price target for 2027?
Ans. The long-term HALEOS LABS share price target for FY27 to FY28 is Rs 2,050 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.
